| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |